| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.71 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |